Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (388)
- Scheduling (national classification system) (171)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
770 result(s) found, displaying 326 to 350
-
Corporate reportsICMRA brings together the heads of over 40 medicines regulatory authorities, with the WHO as an observer.
-
Corporate reportsThe report cards show the progress made by the TGA in the 3 strategies that make up the Action Plan for Medical Devices.
-
Corporate reportsThe number of women in Australia who have had transvaginal mesh implants and related matters.
-
Scheduling decisions (final)Public notice of final decisions - ACMS#33, ACCS#30, Joint ACMS-ACCS#27 (March 2021).
-
Scheduling decisions (final)Notice on an amendment to the current Poisons Standard in relation to ivermectin
-
Corporate reportsHighlights and Achievements from the International Engagement Strategy 2016-2020
-
-
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of listed medicines for Aconitum alkaloid content.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of SAS-supplied cannabis products.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing for toxins in medicinal cannabis products.
-
Corporate reportsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Meeting statementsA meeting statement from the second meeting of the Dental Sector Working Group is now available.
-
Meeting statementsAdvisory Committee on Medical Devices (ACMD) meeting statement.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 27 August 2021
-
Corporate reportsAdvancing Australia's health through international regulatory engagement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 17 August 2021
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 3 February 2021
-
Scheduling decisions (final)Notice of final decisions to amend the Poisons Standard - ACMS #32, Joint ACMS-ACCS #26, ACCS #29 (November 2020).